A validated model of serum anti-müllerian hormone from conception to menopause
- PMID: 21789206
- PMCID: PMC3137624
- DOI: 10.1371/journal.pone.0022024
A validated model of serum anti-müllerian hormone from conception to menopause
Abstract
Background: Anti-Müllerian hormone (AMH) is a product of growing ovarian follicles. The concentration of AMH in blood may also reflect the non-growing follicle (NGF) population, i.e. the ovarian reserve, and be of value in predicting reproductive lifespan. A full description of AMH production up to the menopause has not been previously reported.
Methodology/principal findings: By searching the published literature for AMH concentrations in healthy pre-menopausal females, and using our own data (combined n = 3,260) we have generated and robustly validated the first model of AMH concentration from conception to menopause. This model shows that 34% of the variation in AMH is due to age alone. We have shown that AMH peaks at age 24.5 years, followed by a decline to the menopause. We have also shown that there is a neonatal peak and a potential pre-pubertal peak. Our model allows us to generate normative data at all ages.
Conclusions/significance: These data highlight key inflection points in ovarian follicle dynamics. This first validated model of circulating AMH in healthy females describes a transition period in early adulthood, after which AMH reflects the progressive loss of the NGF pool. The existence of a neonatal increase in gonadal activity is confirmed for females. An improved understanding of the relationship between circulating AMH and age will lead to more accurate assessment of ovarian reserve for the individual woman.
Conflict of interest statement
Figures



Similar articles
-
Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications.Hum Reprod Update. 2014 Sep-Oct;20(5):688-701. doi: 10.1093/humupd/dmu020. Epub 2014 May 12. Hum Reprod Update. 2014. PMID: 24821925 Review.
-
Does anti-Müllerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study.Hum Reprod. 2016 Jul;31(7):1579-87. doi: 10.1093/humrep/dew112. Epub 2016 May 13. Hum Reprod. 2016. PMID: 27179263
-
The utility of measuring anti-Müllerian hormone in predicting menopause.Climacteric. 2015;18(6):777-89. doi: 10.3109/13697137.2015.1036853. Epub 2015 Sep 16. Climacteric. 2015. PMID: 25845388 Review.
-
Serum anti-Mullerian hormone (AMH) concentration has limited prognostic value for density of primordial and primary follicles, questioning it as an accurate parameter for the ovarian reserve.Maturitas. 2020 Apr;134:34-40. doi: 10.1016/j.maturitas.2020.02.001. Epub 2020 Feb 4. Maturitas. 2020. PMID: 32143774
-
Maternal menopause as a predictor of anti-Mullerian hormone level and antral follicle count in daughters during reproductive age.Hum Reprod. 2013 Jan;28(1):247-55. doi: 10.1093/humrep/des356. Epub 2012 Nov 6. Hum Reprod. 2013. PMID: 23136135
Cited by
-
Quantification of anti-Müllerian hormone (AMH) in dried blood spots: validation of a minimally invasive method for assessing ovarian reserve.Hum Reprod. 2012 Aug;27(8):2503-8. doi: 10.1093/humrep/des194. Epub 2012 Jun 6. Hum Reprod. 2012. PMID: 22674205 Free PMC article.
-
Ovarian reserve and IVF outcomes in patients with inflammatory bowel disease: A systematic review and meta-analysis.EClinicalMedicine. 2022 Jul 1;50:101517. doi: 10.1016/j.eclinm.2022.101517. eCollection 2022 Aug. EClinicalMedicine. 2022. PMID: 35812999 Free PMC article.
-
Clinical and self-reported markers of reproductive function in female survivors of childhood Hodgkin lymphoma.J Cancer Res Clin Oncol. 2023 Nov;149(15):13677-13695. doi: 10.1007/s00432-023-05035-z. Epub 2023 Jul 31. J Cancer Res Clin Oncol. 2023. PMID: 37522923 Free PMC article.
-
Factors Associated with Poor Ovarian Reserve in Young Infertile Women: A Hospital-based Cohort Study.J Hum Reprod Sci. 2023 Apr-Jun;16(2):140-147. doi: 10.4103/jhrs.jhrs_28_23. Epub 2023 Jun 30. J Hum Reprod Sci. 2023. PMID: 37547093 Free PMC article.
-
Is AMH a regulator of follicular atresia?J Assist Reprod Genet. 2014 Nov;31(11):1403-7. doi: 10.1007/s10815-014-0328-7. Epub 2014 Sep 6. J Assist Reprod Genet. 2014. PMID: 25193290 Free PMC article. Review.
References
-
- Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocrine Reviews. 2009;30:465–493. - PubMed
-
- Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocrine Reviews. 1996;17:121–155. - PubMed
-
- McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocrine Reviews. 2000;21:200–214. - PubMed
-
- Durlinger AL, Visser JA, Themmen AP. Regulation of ovarian function: the role of anti-Müllerian hormone. Reproduction. 2002;124:601–609. - PubMed
-
- Gigli I, Cushman RA, Wahl CM, Fortune JE. Evidence for a role for anti-Mullerian hormone in the suppression of follicle activation in mouse ovaries and bovine ovarian cortex grafted beneath the chick chorioallantoic membrane. Molecular Reproductive Development. 2005;71:480–488. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical